REGULATED PRESS RELEASE published on 02/11/2025 at 07:01, 1 year 8 months ago bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid bioMérieux receives U.S. FDA clearance for the new version of its molecular test, the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid, targeting causes of gastroenteritis. The test detects 11 common bacteria, viruses, and parasites from one sample in about 1 hour, improving patient outcomes BioMérieux FDA Clearance Gastroenteritis BIOFIRE® FILMARRAY® Molecular Test
PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 8 months ago NORMA Group completes a challenging financial year 2024 with a stable level of profitability NORMA Group successfully concludes 2024 with stable profitability. Preliminary figures show sales of EUR 1.2 billion, adjusted EBIT at EUR 92.3 million, and strong cash flow. Divestment of Water Management business initiated Market Challenges Profitability 2024 Financial Results NORMA Group Divestment Process
PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 8 months ago BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE BioVersys advances BV500 NTM program with continued support from CF AMR Syndicate, developing therapies for NTM lung disease in CF patients. Company focuses on antibacterial products against MDR bacteria BioVersys BV500 NTM Program CF AMR Syndicate NTM Lung Disease MDR Bacteria
PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 8 months ago TUI Group: 10th consecutive quarter of Und. EBIT growth – Hotels, Cruises and TUI Musement driving improvement in FY25 Q1 TUI Group reports 10th consecutive quarter of underlying EBIT growth in FY25 Q1, driven by Hotels, Cruises, and TUI Musement. Q1 revenue up +13% to €4.9bn. Market + Airline segment shows 31% lower underlying EBIT due to investments for summer season Revenue Growth Underlying EBIT TUI Group FY25 Q1 Market + Airline
PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 8 months ago Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 Relief Therapeutics obtains European Patent Office grant for RLF-TD011, securing patent protection for epidermolysis bullosa treatment. Company advances wound care solution Relief Therapeutics European Patent Office Epidermolysis Bullosa Wound Treatment RLD-TD011
REGULATED PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 8 months ago Biophytis dévoile ses perspectives stratégiques de l’année 2025 Biophytis dévoile ses perspectives stratégiques pour l’année 2025, incluant le lancement de nouveaux programmes cliniques et des collaborations clés dans le domaine des maladies liées à l'âge Stratégie Biophytis Partenariats Développement Clinique Maladies Liées À L'âge
REGULATED PRESS RELEASE published on 02/11/2025 at 07:00, 1 year 8 months ago Biophytis unveils its outlook strategies for 2025 Biophytis unveils its strategic outlook for 2025, focusing on clinical development and commercialization plans for BIO101 (20-Hydroxyecdysone) in obesity and sarcopenia, with key partnerships and agreements Biophytis Clinical Development BIO101 Obesity Strategic Outlook
PRESS RELEASE published on 02/11/2025 at 06:58, 1 year 8 months ago Board member Christina Johansson passes away Emmi Group announces the passing of Board member Christina Johansson, a valued financial expert and Chairwoman of the Audit Committee Board Member Emmi Group Audit Committee Financial Expert Christina Johansson
PRESS RELEASE published on 02/11/2025 at 06:58, 1 year 8 months ago Décès de Christina Johansson, membre du Conseil d'administration Décès de Christina Johansson, membre du Conseil d'administration du groupe Emmi. Annonce officielle avec condoléances et hommage au travail accompli Conseil D'administration Décès Emmi Christina Johansson Condoléances
PRESS RELEASE published on 02/11/2025 at 06:57, 1 year 8 months ago ALSO enters US - First step: Cloud ALSO Holding AG expands into the US market with a focus on cloud solutions, leveraging the country's large economy and high cloud usage. The company aims to drive cloud migrations, enhance cybersecurity, and promote AI adoption Expansion US Market ALSO Holding AG Cloud Solutions IT Services
Published on 11/06/2026 at 22:15, 3 hours 20 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 12 hours 35 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 13 hours 5 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 13 hours 5 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 5 hours 20 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 5 hours 20 minutes ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 6 hours 20 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 6 hours 35 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 7 hours 3 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 19:06, 6 hours 28 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 6 hours 31 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 6 hours 33 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 6 hours 35 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL